Inositol: Effects on oocyte quality in patients undergoing ICSI. An open study

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 22, 2013, Pages 3095-3102

  Brusco, Gian Francesco ^a   Mariani, M ^a  

^a Perugia Hospital   (Italy)

Author keywords

D chiro inositol; Embryo quality assessment; Myo inositol; Oocyte quality assessment

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DEXTRO CHIRO INOSITOL; FOLIC ACID; INOSITOL; INOSITOL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AZOOSPERMIA; CELL SIZE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MALE INFERTILITY; MICROENVIRONMENT; OOCYTE DEVELOPMENT; OOCYTE MATURATION; OOCYTE QUALITY; OOCYTE RETRIEVAL; OPEN STUDY; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

FEMALE; FOLIC ACID; HUMANS; INOSITOL; MALE; OOCYTES; PREGNANCY; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84891812104     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. NESTLER JE, JAKUBOWICZ DJ, REAMER P, GUNN RD, ALLAN G. Ovulatory and metabolic effects of D chiroinositol in the polycystic ovary syndrome. N Engl J Med 1999; 340: 1314-1320.
2. PAPALEO E, UNFER V, BAILLARGEON JP, FUSI F, OCCHI F, DE SANTIS L. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled randomized trial. Fertil Steril 2009; 91: 1750-1754.
3. RIENZI L, BALABAN B, EBNER T, MANDELBAUM J. The oocyte. Hum Reprod 2012; 27 Suppl 1: 12-21.
4. EBNER T, MOSER M, TEWS G. Is oocyte morphology prognostic of embryo developmental potential after ICSI? Reprod Biomed Online 2006; 12: 507-512.
5. LAUFER N, TARLATZIS BC, DECHERNEY AH, MASTERS JT, HASELTINE FP, MACLUSKY N, NAFTOLIN F. Asynchrony between human cumulus-corona cell complex and oocyte maturation after human menopausal gonadotropin treatment for in vitro fertilization. Fertil Steril 1984; 42: 366-372.
6. VAN BLERKOM J, HENRY G. Oocyte dismorphism and aneuploidy in meiotically mature human oocytes after ovarian stimulation. Hum Reprod 1992; 7: 379-390.
7. ALPHA SCIENTISTS IN REPRODUCTIVE MEDICINE AND ESHRE SPECIAL INTEREST GROUP OF EMBRYOLOGY. The Instanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 2011; 26: 1270-1283.
8. EHRMANN DA. Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223-1236.
9. EBNER T, SHEBL O, MOSER M, SOMMERGRUBER M, TEWS G. Developmental fate of ovoid oocytes. Hum Reprod 2008; 23: 62-66.
10. OTSUKI J, OKADA A, MORIMOTO K, NAGAI Y, KUBO H. The relationship between pregnancy outcome and smooth endoplasmic reticulum clusters in MII human oocytes. Hum Reprod 2004; 19: 1591-1597.
11. EBNER T, MOSER M, SHEBL O, SOMMERGRUBER M, TEWS G. Prognosis of oocytes showing aggregation of smooth endoplasmic reticulum. Reprod Biomed Online 2008; 16: 113-118.
12. AKARSU C, CAGLAR G, VICDAN K, SÖZEN E, BIBERO LU K. Smooth endoplasmic reticulum aggregations in all retrieved oocytes causing recurrent multiple anomalies: case report. Fertil Steril 2009; 92: 1496-1498.
13. ZIEBE S, LUNDIN K, LOFT A, BERGH C, NYBOE ANDERSEN A, SELLESKOG U, NIELSEN D, GRØNDAHL C, KIM H, ARCE JC; CEMAS II AND STUDY GROUP. FISH analysis for chromosomes 13, 16, 18, 21, 22, X and Y in all blastomeres of IVF pre-embryos from 144 randomly selected donated human oocytes and impact on pre-embryo morphology. Hum Reprod 2003; 18: 2575-2581.
14. HARDARSON T, HANSON C, SIOGREN A, LUNDIN K. Human embryos with unevenly sized blastomeres have lower pregnancy and implantation rates: indications for aneuploidy and multinucleation. Hum Reprod 2001; 16: 313-318.
15. PUISSANT F, VAN RYSSELBERGE M, BARLOW P, BARLOW P, DEWEZE J, LEROY F. Embryo scoring as a prognostic tool in IVF treatment. Hum Reprod 1987; 2: 705-708.
16. GIORGETTI C, TERRIOU P, AUQUIER P, HANS E, SPACH JL, SALZMANN J, ROULIER R. Embryo score to predict implantation after in-vitro fertilization: based on 957 single embryo transfers. Hum Reprod 1995; 10: 2427-2431.
17. ZIEBE S, PETERSEN K, LINDERBERG S, ANDERSEN AG, GABRIELSEN A, ANDERSEN AN. Embryo morphology or cleavage stage: how to select the best embryos for transfer after in-vitro fertilization. Hum Reprod 1997; 12: 1545-1549.
18. The International Committee for Monitoring Assisted Reproductive Technology, ICMART, and World Health Organization, WHO, Revised Glossary on ART Terminology, 2009.
19. CHIU TTY, ROGERS MS, LAW ELK, BRITON-JONES CM, CHEUNG LP, HAINES CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod 2002; 17: 1591-1596.
20. CHIU TTY, ROGERS MS, BRITON-JONES CM, HAINES C. Effect of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes. Hum Reprod 2003; 18: 408-416.
21. STRACQUADANIO M, CIOTTA L, PAGANO I, CARBONARO A, PALUMBO M, GULINO F. Effetti dell'inositolo sulla qualità ovocitaria in pazienti affette da sindrome dell'ovaio policistico. Riv It Ost Gin 2010; 27: 249-254.
22. GOUD PT, GOUD AP, OOSTVELDT PV, DHONT M. Presence and dynamic redistribution of type I inositol, 1,4,5-triphosphate receptor in human oocytes and embryos during in-vitro maturation, fertilization and early cleavage division. Mol Hum Reprod 1999; 5: 441-451.
23. GERLI S, MIGNOSA M, DI RENZO GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci 2003; 7: 151-159.
24. COSTANTINO D, MINOZZI G, MINOZZI E, GUARALDI C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci 2009; 13: 105-110.